Clinical trials
Pharmalittle: Eyepoint Faces Setback, Amylyx Sees Win, and More
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal, while Amylyx's Avexitide shows promise.
#primary
Every Medical Research story tagged primary.
Clinical trials
Eyepoint Study Results Disappoint for Vision Treatment
Eyepoint's experimental treatment for age-related blindness fails to meet primary goal in Phase 3 clinical trial.